The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cantley Lewis Clayton Jr. since 2015.
The trader's CIK number is 1581950.
At the time of the last reporting, Cantley Lewis Clayton Jr. was the Director of Agios Pharmaceuticals, Inc.. (stock ticker symbol AGIO).
Also see all insider trading activities at Agios Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | AGIO | 0 | $0 | 40,000 | $2,335,920 | 0 | $0 |
2016 | AGIO | 0 | $0 | 22,536 | $1,027,222 | 0 | $0 |
2015 | AGIO | 0 | $0 | 97,704 | $8,767,402 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-12-06 | AGIO | Sale | 2,000 | 58.95 | 117,906 |
2017-12-07 | AGIO | Sale | 1,838 | 60.06 | 110,399 |
2017-11-13 | AGIO | Sale | 2,000 | 62.07 | 124,140 |
2017-11-14 | AGIO | Sale | 2,000 | 59.91 | 119,820 |
2017-10-16 | AGIO | Sale | 2,000 | 71.09 | 142,180 |
2017-10-17 | AGIO | Sale | 2,000 | 71.10 | 142,200 |
2017-09-14 | AGIO | Sale | 2,000 | 65.71 | 131,420 |
2017-09-13 | AGIO | Sale | 2,000 | 65.47 | 130,940 |
2017-08-22 | AGIO | Sale | 2,000 | 56.62 | 113,240 |
2017-08-23 | AGIO | Sale | 2,000 | 57.08 | 114,160 |
2017-07-19 | AGIO | Sale | 7,000 | 56.13 | 392,910 |
2017-07-20 | AGIO | Sale | 2,000 | 57.12 | 114,250 |
2017-06-13 | AGIO | Sale | 1,000 | 50.64 | 50,640 |
2017-06-14 | AGIO | Sale | 1,000 | 51.09 | 51,090 |
2017-05-25 | AGIO | Sale | 1,018 | 46.92 | 47,764 |
2017-05-24 | AGIO | Sale | 1,018 | 47.27 | 48,120 |
2017-04-17 | AGIO | Sale | 4,072 | 55.20 | 224,774 |
2017-04-18 | AGIO | Sale | 1,018 | 50.92 | 51,836 |
2017-03-22 | AGIO | Sale | 1,018 | 52.31 | 53,251 |
2017-03-23 | AGIO | Sale | 1,018 | 53.91 | 54,880 |
2016-10-27 | AGIO | Sale | 1,252 | 48.97 | 61,310 |
2016-10-26 | AGIO | Sale | 1,252 | 48.91 | 61,235 |
2016-09-27 | AGIO | Sale | 1,252 | 54.15 | 67,795 |
2016-09-28 | AGIO | Sale | 1,252 | 54.00 | 67,608 |
2016-08-29 | AGIO | Sale | 1,252 | 37.81 | 47,338 |
2016-08-30 | AGIO | Sale | 1,252 | 36.81 | 46,086 |
2016-07-26 | AGIO | Sale | 1,252 | 43.74 | 54,762 |
2016-07-25 | AGIO | Sale | 1,252 | 41.85 | 52,396 |
2016-06-27 | AGIO | Sale | 1,252 | 40.37 | 50,543 |
2016-06-28 | AGIO | Sale | 1,252 | 43.38 | 54,311 |
2016-05-25 | AGIO | Sale | 1,252 | 50.50 | 63,226 |
2016-05-26 | AGIO | Sale | 1,252 | 52.88 | 66,205 |
2016-04-25 | AGIO | Sale | 1,252 | 55.00 | 68,860 |
2016-04-26 | AGIO | Sale | 1,252 | 51.88 | 64,953 |
2016-03-30 | AGIO | Sale | 1,252 | 38.09 | 47,688 |
2016-03-29 | AGIO | Sale | 1,252 | 36.28 | 45,422 |
2016-01-28 | AGIO | Sale | 1,252 | 44.33 | 55,501 |
2016-01-29 | AGIO | Sale | 1,252 | 41.52 | 51,983 |
2015-12-28 | AGIO | Sale | 5,324 | 63.73 | 339,271 |
2015-12-29 | AGIO | Sale | 5,340 | 66.14 | 353,160 |
2015-11-16 | AGIO | Sale | 2,426 | 59.38 | 144,055 |
2015-11-17 | AGIO | Sale | 6,982 | 59.98 | 418,815 |
2015-10-23 | AGIO | Sale | 4,852 | 61.10 | 296,481 |
2015-10-22 | AGIO | Sale | 4,852 | 61.22 | 297,015 |
2015-09-24 | AGIO | Sale | 4,852 | 84.42 | 409,630 |
2015-09-25 | AGIO | Sale | 4,852 | 82.08 | 398,252 |
2015-08-18 | AGIO | Sale | 4,852 | 95.69 | 464,287 |
2015-08-17 | AGIO | Sale | 4,852 | 94.19 | 457,034 |
2015-07-15 | AGIO | Sale | 4,852 | 114.36 | 554,898 |
2015-07-16 | AGIO | Sale | 4,852 | 114.19 | 554,025 |
2015-06-24 | AGIO | Sale | 4,852 | 104.59 | 507,494 |
2015-06-25 | AGIO | Sale | 4,852 | 105.66 | 512,662 |
2015-05-19 | AGIO | Sale | 4,852 | 116.67 | 566,107 |
2015-05-20 | AGIO | Sale | 4,852 | 116.60 | 565,743 |
2015-04-23 | AGIO | Sale | 4,852 | 103.83 | 503,758 |
2015-04-24 | AGIO | Sale | 4,852 | 106.47 | 516,592 |
2015-03-26 | AGIO | Sale | 4,852 | 90.83 | 440,682 |
2015-03-27 | AGIO | Sale | 4,852 | 96.34 | 467,441 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cantley Lewis Clayton Jr. (Director of Agios Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.